CS208162B2 - Method of making the macroagregates of the technicium-99m,albumine and tin ion - Google Patents
Method of making the macroagregates of the technicium-99m,albumine and tin ion Download PDFInfo
- Publication number
- CS208162B2 CS208162B2 CS517172A CS517172A CS208162B2 CS 208162 B2 CS208162 B2 CS 208162B2 CS 517172 A CS517172 A CS 517172A CS 517172 A CS517172 A CS 517172A CS 208162 B2 CS208162 B2 CS 208162B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- albumin
- solution
- macroaggregates
- added
- technetium
- Prior art date
Links
- 229910001432 tin ion Inorganic materials 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 108010088751 Albumins Proteins 0.000 claims abstract description 54
- 102000009027 Albumins Human genes 0.000 claims abstract description 54
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 claims abstract description 12
- 229940056501 technetium 99m Drugs 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 20
- 108010013207 macro aggregates of albumin Proteins 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- -1 tin (II) halide Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 13
- 210000004072 lung Anatomy 0.000 abstract description 9
- 239000006228 supernatant Substances 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 5
- 230000002285 radioactive effect Effects 0.000 abstract description 5
- 229910021626 Tin(II) chloride Inorganic materials 0.000 abstract description 4
- 235000011150 stannous chloride Nutrition 0.000 abstract description 4
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 3
- 239000001119 stannous chloride Substances 0.000 abstract description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract description 2
- 102000008946 Fibrinogen Human genes 0.000 abstract description 2
- 108010049003 Fibrinogen Proteins 0.000 abstract description 2
- 108010044091 Globulins Proteins 0.000 abstract description 2
- 102000006395 Globulins Human genes 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 102000008100 Human Serum Albumin Human genes 0.000 abstract description 2
- 108091006905 Human Serum Albumin Proteins 0.000 abstract description 2
- ZSUXOVNWDZTCFN-UHFFFAOYSA-L Tin(II) bromide Inorganic materials Br[Sn]Br ZSUXOVNWDZTCFN-UHFFFAOYSA-L 0.000 abstract description 2
- JTDNNCYXCFHBGG-UHFFFAOYSA-L Tin(II) iodide Inorganic materials I[Sn]I JTDNNCYXCFHBGG-UHFFFAOYSA-L 0.000 abstract description 2
- 239000008121 dextrose Substances 0.000 abstract description 2
- 229940012952 fibrinogen Drugs 0.000 abstract description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract description 2
- 229940108184 stannous iodide Drugs 0.000 abstract description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 abstract 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 238000003759 clinical diagnosis Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000012857 radioactive material Substances 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 239000008215 water for injection Substances 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002358 iodine Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16445671A | 1971-07-20 | 1971-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS208162B2 true CS208162B2 (en) | 1981-08-31 |
Family
ID=22594567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS517172A CS208162B2 (en) | 1971-07-20 | 1972-07-20 | Method of making the macroagregates of the technicium-99m,albumine and tin ion |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5637211B2 (enrdf_load_stackoverflow) |
| CS (1) | CS208162B2 (enrdf_load_stackoverflow) |
| GB (1) | GB1403384A (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3863004A (en) * | 1972-03-20 | 1975-01-28 | Mallinckrodt Chemical Works | Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation |
| GB1389809A (en) * | 1972-06-05 | 1975-04-09 | Medi Physics Inc | 99m-technetium labeled macroaggregated human serum albumin pharmaceutical |
| JPS51100470A (en) * | 1975-02-24 | 1976-09-04 | Sumitomo Chemical Co | Hiryokuioyobi sonoseizoho |
| JPS5681942U (enrdf_load_stackoverflow) * | 1979-11-30 | 1981-07-02 | ||
| JP2642874B2 (ja) * | 1994-07-11 | 1997-08-20 | 工業技術院長 | 被覆肥料の製造方法およびその製品 |
-
1972
- 1972-07-20 GB GB3406272A patent/GB1403384A/en not_active Expired
- 1972-07-20 JP JP7301272A patent/JPS5637211B2/ja not_active Expired
- 1972-07-20 CS CS517172A patent/CS208162B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1403384A (en) | 1975-08-28 |
| JPS4839546A (enrdf_load_stackoverflow) | 1973-06-11 |
| JPS5637211B2 (enrdf_load_stackoverflow) | 1981-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zolle et al. | Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation | |
| Rhodes et al. | Radioactive albumin microspheres for studies of the pulmonary circulation | |
| CA1245980A (en) | Physiologic chemical method of labeling protein substances with the radionuclides of indium | |
| Ferrebee et al. | Insulin and adrenocorticotropin labeled with radio-iodine | |
| AU656915B2 (en) | Stabilized therapeutic radiopharmaceutical complexes | |
| Schneider et al. | The role and fate of rabbit and human transcobalamin II in the plasma transport of vitamin B12 in the rabbit. | |
| CA2279349C (en) | Ascorbate-stabilized radiopharmaceutical method and composition | |
| NO174326B (no) | Anveldelse av maalsoekende merket polypeptid | |
| US3872226A (en) | Tc{14 99m albumin aggregates with stannous tin and denatured albumin | |
| US3992513A (en) | Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs | |
| JPS58146514A (ja) | テクネチウム−９９ｍで標識付けされるべき対象探査性配位子および非一対象探査性還元体を有する容器 | |
| Pressman et al. | The nature of the combining sites of antibodies: the specific protection of the combining site by hapten during iodination | |
| US3803299A (en) | Method of producing a diagnostic preparation on the basis of macro-aggregates of serum albumin labelled with | |
| CS208162B2 (en) | Method of making the macroagregates of the technicium-99m,albumine and tin ion | |
| WO1991009628A1 (de) | Verwendung eines antikoagulant als diagnostikum | |
| Spar et al. | Preparation of purified I131-labeled antibody which reacts with human fibrin. Preliminary tracer studies on tumor patients | |
| WO1985003231A1 (en) | TECHNETIUM-99m COMPOSITION FOR LABELLING PROTEINACEOUS MATERIAL AND METHOD | |
| Harwig et al. | In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent | |
| US3743714A (en) | Novel carrier preparations for injectable radioactive compositions | |
| EP1713516B1 (de) | Verfahren und kit zur herstellung von rhenium-188 markierten partikeln | |
| Fairley et al. | The production of anti‐human‐globulin sera of different specificities in rabbits | |
| EP1004321B1 (en) | Stable radioactive medecine | |
| Honda et al. | Instant labeling of macro-and microaggregated albumin with 99mTc | |
| Hnatowich et al. | The importance of pH and citrate concentration on the in vitro and in vivo behavior of radiogallium | |
| Bale et al. | In Vivo Purification of I131 Labeled Localizing Antirat Lymphosarcoma Antibody |